Identification of a novel luminal molecular subtype of breast cancer.
The molecular classification of human breast tumors has afforded insights into subtype specific biological processes, patient prognosis and response to therapies. However, using current methods roughly one quarter of breast tumors cannot be classified into one or another molecular subtype. To explor...
Main Authors: | Anna Dvorkin-Gheva, John A Hassell |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4116208?pdf=render |
Similar Items
-
Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples.
by: Anna Dvorkin-Gheva, et al.
Published: (2011-01-01) -
Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
by: Ting Huang, et al.
Published: (2023-04-01) -
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
by: Kirsi Holli-Helenius, et al.
Published: (2017-12-01) -
MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
by: Dorsay Sadeghian, et al.
Published: (2022-02-01) -
Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
by: Atif Ali Hashmi, et al.
Published: (2018-01-01)